The mission of SNBL Group is to free patients from suffering by supporting drug development and improving medical technology. The nonclinical research division of SNBL is Japan’s largest and oldest nonclinical CRO. For over 65 years, we have balanced speed with superior quality, carrying out studies efficiently, accurately and in a timely manner, consistently exceeding our customers’ expectations; because this is not just a job, it’s our passion. At SNBL, we embrace the challenges of innovation, growth and development in order to provide a meaningful contribution to the well-being of all people. Contact us at info@snbl.co.jp today to learn more about our capabilities.
| Website | https://snbl.com/ |
| Revenue | $23.4 million |
| Employees | 252 (92 on RocketReach) |
| Founded | 1957 |
| Industry | Biotechnology Research, Drug Discovery, Other Pharmaceuticals and Biotechnology |
| Keywords | Drug Development, Pharmaceutical Research, Preclinical Research, Drug Discovery, Medical Technology, Contract Research, Biopharmaceutical Services, Toxicology Testing, Safety Assessment, Pharmaceutical Services, In Vivo Studies, Pharmacokinetics, Pharmacodynamics, Clinical Trials, Life Sciences, Biotechnology, Regulatory Affairs, Healthcare Research, Animal Testing |
Looking for a particular SNBL employee's phone or email?
The SNBL annual revenue was $23.4 million in 2026.
Nagata Ichiro is the COO, Representative Director, Executive Vice President of SNBL.
92 people are employed at SNBL.